Did Mike Tyson Get Stem Cell Therapy? The Full, Fact-Checked Timeline

Quick answer: Yes. Mike Tyson has discussed undergoing stem cell therapy on two separate, well-documented occasions — first in 2020 ahead of his exhibition bout with Roy Jones Jr., and again in 2024 ahead of his fight with Jake Paul, when reports connected him to the Cellular Performance Institute (CPI) in Tijuana, Mexico. He has never released medical records confirming exact cell type, dose, or diagnosis, so most of what’s public comes from his own interviews and social media, not clinical documentation.

Below is the full, sourced timeline, what “stem cell therapy” actually means in this context, why so many combat-sport athletes use regenerative treatments, and what current research does and doesn’t support.

2020: The Instagram Live confession to Shaquille O'Neal

The first time Tyson spoke about this publicly was during an Instagram Live conversation with NBA Hall of Famer Shaquille O’Neal in spring 2020, just as Tyson was training for what would become his exhibition bout against Roy Jones Jr. at age 53, after roughly 15 years without stepping into a boxing ring.

View this post on Instagram

Tyson told O’Neal he’d had “stem-cell research therapy” and described the effect in blunt, characteristically Tyson terms — saying it left him feeling like a different person, though he admitted he couldn’t fully explain why. He didn’t name a clinic, a diagnosis, or a specific cell source in that conversation. He also credited three days of hitting the bag with feeling “incredible” after a 15-year layoff — a detail worth noting, because it shows Tyson himself framed the therapy as one factor among several (training, diet, discipline), not a stand-alone fix

The Joe Rogan "cheating" controversy

Around the same time, UFC commentator Joe Rogan publicly questioned whether Tyson’s explosive speed and power in training clips looked “natural” for a man in his 50s. Tyson responded directly, confirming the stem cell treatment as part of his answer. That exchange is what pushed the story from boxing-forum chatter into mainstream sports media, and it’s also what kicked off a genuine ethical debate: should regenerative treatments that speed up recovery be treated differently from performance-enhancing drugs in combat sports? There’s no governing-body consensus on this yet, and it remains an open question in sports medicine and athletic commissions.

2024: Tyson, CPI, and the Jake Paul fight

The story resurfaced in late 2024 as Tyson prepared for his exhibition against Jake Paul. Multiple combat-sports outlets, including coverage tied to the Joe Rogan Experience’s “Fight Companion” episodes, reported that Tyson had sought treatment at the Cellular Performance Institute (CPI) in Tijuana, a clinic that has marketed itself as a stem cell provider to UFC-affiliated athletes. Tijuana’s regenerative-medicine clinics operate under Mexican regulatory frameworks that are considerably less restrictive than the FDA’s rules for stem cell products in the United States, which is part of why the border-clinic model exists in the first place — patients and athletes go there specifically because certain cell-based treatments aren’t approved for those uses in the U.S.

Worth flagging: this round of reporting is secondhand — it comes from commentary and industry write-ups, not a direct, on-record Tyson interview naming the clinic himself. Treat it as credible-but-unconfirmed by Tyson personally, distinct from his own 2020 statements.

What kind of stem cell therapy was it, medically speaking?

Tyson has never publicly specified the exact protocol, so anything beyond his own description is informed inference, not confirmed fact. Based on what’s typical for this category of treatment and consistent with how he described it, the most likely category is an autologous procedure — meaning cells or cell-rich components are drawn from Tyson’s own body (commonly bone marrow or adipose/fat tissue), concentrated in a lab or clinic setting, and reinjected into the target area.

A few terms worth untangling, since they get used loosely in media coverage and marketing alike:

Term	What it actually is
Mesenchymal stem cells (MSCs)	Cells typically harvested from bone marrow or fat tissue, studied for their potential to modulate inflammation and support tissue repair
PRP (platelet-rich plasma)	Not a stem cell product — it's concentrated platelets from the patient's own blood, used for similar recovery goals but via a biologically different mechanism
Exosomes	Cell-derived signaling particles, sometimes used alongside or instead of whole cells; distinct from "stem cells" despite frequent marketing overlap
Amniotic/umbilical-derived products	Allogeneic (donor-derived) products marketed by some clinics; regulatory status varies significantly by country

Because these terms are so often blurred in press coverage and clinic marketing, it’s genuinely unclear from public reporting alone which category Tyson received. That ambiguity is worth being upfront about rather than glossing over.

Why boxers and combat athletes turn to regenerative medicine

A 20-year professional boxing career puts sustained, repetitive stress on joints, the spine, and soft tissue in a way few other sports match. Common post-career complaints among retired fighters include:

Chronic joint pain, especially shoulders, knees, and the lower back
Reduced range of motion after years of scar tissue buildup
Slower recovery between training sessions
General deconditioning and weight gain after retirement
In some cases, concerns about cumulative head trauma (a separate issue from joint/soft-tissue therapy, and one current stem cell research has not resolved)

Tyson’s public comments track closely with these ordinary post-retirement complaints — pain, stiffness, wanting mobility back — rather than any specific diagnosis. That’s a meaningfully different, and more modest, claim than “stem cells reversed his aging” or similar language sometimes used in marketing contexts.

What the research actually shows

This is the part most celebrity-adjacent coverage skips, so it’s worth being direct about it:

Orthopedic applications (joint pain, tendon and ligament injuries) have the most research behind them, including some randomized controlled trials on MSC injections for knee osteoarthritis. Results are mixed-to-promising, with meaningful study-to-study variation in cell dose, source, and preparation — the field has not converged on standardized protocols yet.
Systemic “anti-aging” or full-body rejuvenation claims are not well supported by current peer-reviewed evidence, regardless of how they’re marketed.
Regulatory status matters: in the United States, most stem cell products for orthopedic and recovery use fall outside FDA approval and are officially classified as investigational/experimental — which is also why U.S. patients and athletes often travel to Mexico or elsewhere for treatments not available domestically.
Anecdotal outcomes — including a fit-looking, fast-moving Tyson in training footage — are not clinical evidence of efficacy on their own, since they’re confounded by training load, diet changes, and (as Tyson himself has said) months of dedicated conditioning.

None of this means the treatments don’t help some patients; it means the evidence base is still developing, and claims should be sized to match that.

Risks, regulation, and the "experimental" label

Because these procedures are not FDA-approved for most orthopedic and recovery indications, oversight, cell sourcing, and clinic standards vary widely — which is exactly why choosing a clinic with genuine medical oversight, transparent sourcing, and realistic expectations matters more than any celebrity association. Reputable clinics will say plainly that outcomes vary by patient and that a treatment is not a guaranteed cure — because, under FDA classification, it isn’t one.

FAQ: Mike Tyson and stem cell therapy

Did Mike Tyson confirm he had stem cell therapy?

Yes, in his own words, twice — in a 2020 Instagram Live with Shaquille O'Neal, and again in the context of his 2024 fight prep, though the 2024 clinic details come from secondhand reporting rather than a direct Tyson statement.

What clinic did Mike Tyson use?

Is stem cell therapy the same as PRP?

Is stem cell therapy legal in Mexico?

Is stem cell therapy considered cheating in boxing?

Does stem cell therapy actually work for joint pain and recovery?

Final take

Tyson’s stem cell story holds up under scrutiny better than a lot of celebrity health claims do — he said it in his own words, on the record, more than once, and the timeline is corroborated across independent outlets. What isn’t fully confirmed is the specific protocol, dose, or diagnosis, and that distinction matters if you’re researching this for your own decision-making rather than just curiosity.

If you’re looking into regenerative treatment for joint pain, old injuries, or post-training recovery, the honest starting point is the same regardless of which celebrity brought the topic to your attention: get a real evaluation, ask what cell type and source are actually being used, and treat marketing claims with the same skepticism you’d want a doctor to have. For readers researching options in Mexico specifically, R3 Stem Cell Mexico offers consultations that walk through what’s realistic for a given case.

This article is for informational purposes only and is not medical advice. Stem cell therapy is classified as experimental by the U.S. FDA and is not FDA-approved for the conditions discussed here. Always consult a licensed physician before pursuing any regenerative treatment.

I agree to receive marketing messages from the business.Message and data rates may apply.Message frequency varies. Text HELP for help.Text STOP to unsubscribe.

I understand stem cell therapy is not covered by insurance and is paid out of pocket.

I consent to R3 Stem Cell referencing the details of my message, including any health information I provide, when contacting me by phone, voicemail, email, or text.

Dr. David Greene

MD, PhD, MBA

Dr. David Greene, MD, PhD, MBA, is a pioneering leader in regenerative medicine and healthcare marketing. As a residency and fellowship-trained orthopedic surgeon, Dr. Greene transitioned from clinical practice to become the founder and CEO of R3 Stem Cell and US Lead Network, where he has revolutionized patient care and medical practice growth through innovative therapies and digital marketing strategies. He has authored two influential books on healthcare internet marketing, ranks among the top expert authors globally, and has been featured on the cover of Corporate Vision magazine for his impact on global regenerative therapies. Beyond his professional achievements, Dr. Greene is passionate about education, compassion, and continuous innovation.